Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Tempus AI, Inc. - Class A Common Stock (NQ: TEM )

43.87 +1.95 (+4.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 519,513
Open 41.71
Bid (Size) 44.00 (1)
Ask (Size) 44.05 (2)
Prev. Close 41.92
Today's Range 41.42 - 44.17
52wk Range 22.89 - 45.11
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 AI-in-Healthcare Stocks to Buy for Outsized Returns
These are the AI healthcare stocks to buy as they represent medical technology investing in research and development for accelerated growth. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Growth Stocks That Can Create Millionaires by 2030
These are the millionaire-maker growth stocks to buy as they represent companies with good fundamentals and a big addressable market. 
Via InvestorPlace

Performance

YTD
+8.99%
+8.99%
1 Month
+31.58%
+31.58%
3 Month
+8.99%
+8.99%
6 Month
+8.99%
+8.99%
1 Year
+8.99%
+8.99%

More News

Read More
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
Via Benzinga
7 Millionaire-Making Growth Stocks to Buy and Forget
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Tempus to Report Second Quarter 2024 Financial Results on August 6
From Tempus AI, Inc.
Via Business Wire
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests
From Tempus AI, Inc.
Via Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
3 Under-the-Radar IPO Stocks to Buy Before They Double
Via InvestorPlace
Topics Initial Public Offering
Exposures Securities Market
IPOs 2024: Tempus AI Addresses Medical Diagnostic Use Case
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tempus Surpasses 500 Research Publications
From Tempus AI, Inc.
Via Business Wire
Tempus AI Has Massive Market Opportunity For This Healthcare Technology, Bullish Analyst Says
Via Benzinga
Topics Artificial Intelligence Initial Public Offering
Exposures Artificial Intelligence Securities Market
Tempus Could Gain Share In AI Health Care Market Poised To Grow By Over 30%
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM
From Tempus AI, Inc.
Via Business Wire
IPO Watch: 3 New Stocks Worth a Strong Look
Via InvestorPlace
Topics Artificial Intelligence Initial Public Offering
Exposures Artificial Intelligence Securities Market
3 New IPOs That Could Be the Next Big Thing
Via InvestorPlace
Why Tempus AI (TEM) Stock Is Rising
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test
From Tempus AI, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Trump Media & Technology And Grindr Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 23 - June 29): Are These In Your Portfolio?
Via Benzinga
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Masayoshi Son's SoftBank To Raise $1.86B Through Bond Issuance For AI Investment And Debt Repayment
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
SoftBank Bets Big On AI In Healthcare: Inks New Joint Venture with Tempus To Transform Cancer Treatment In Japan
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib
From Tempus
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.